Goal Protocol
Sexual Wellness
A hormone-aware path for desire, arousal and endocrine signaling that starts with safety screening and medication context.
Sexual wellness is a signal from many systems at once — hormones, cardiovascular health, sleep, mood and relationship context. When one of them is off, desire and function tend to follow. This protocol starts with that broader picture, not the symptom.
PT-141 and Kisspeptin-10 act on central pathways of desire and hormonal signaling, while Oxytocin supports connection, arousal and orgasm. Each is used for a specific reason — none is a universal fix, and all work best when the underlying hormonal and cardiovascular picture has been evaluated.
For most people, meaningful improvement comes from combining a targeted peptide with attention to sleep, stress, alcohol intake and, where relevant, hormone-replacement decisions with a qualified clinician.
PT-141 activates central melanocortin receptors that drive desire and arousal independent of the vascular pathway that PDE5 inhibitors use. Kisspeptin-10 sits at the top of the reproductive hormonal axis, upregulating GnRH, LH and downstream sex-hormone production. Oxytocin promotes pair-bonding, arousal and orgasm intensity through OXTR signaling in reproductive and reward circuits.
Full hormonal panel, cardiovascular risk review, medication list, sleep and stress audit. Address the largest drivers first.
Introduce a single peptide chosen for the primary complaint — PT-141 for desire, Kisspeptin-10 for hormonal support, Oxytocin for connection and arousal. Use as-needed rather than daily where possible.
Continue what worked at the lowest effective frequency. Recheck hormones every six months if using Kisspeptin-10 chronically.
Erection and arousal are vascular events — blood pressure, lipids and glucose control are directly cosmetic here.
Chronic under-sleep and unmanaged stress suppress testosterone and libido in both sexes.
Alcohol, SSRIs, beta-blockers and finasteride are common but under-recognised contributors — a medication review often changes more than a peptide.
Relationship context sets the ceiling on what any molecule can deliver.
PT-141 typically works within one to two hours of dosing. Kisspeptin-driven hormonal shifts take weeks. Oxytocin effects are situational and short-acting. Sustained improvement almost always requires the lifestyle levers, not just the injection.
- Total and free testosterone
- SHBG
- Estradiol (sensitive assay)
- LH, FSH
- Prolactin
- DHEA-S
- TSH
- Fasting glucose and HbA1c
- Lipid panel
- PSA (men over 40)
- Urinalysis
- 24-hour urinary free cortisol (if HPA involvement suspected)
- PT-141 raises blood pressure transiently — not appropriate in uncontrolled hypertension or significant cardiovascular disease.
- Kisspeptin-driven stimulation is not appropriate in hormone-sensitive cancers.
- Sudden loss of libido or function often has a treatable cause (thyroid, prolactin, medication) — investigate before self-treating.
Educational content only. Not medical advice. Speak with a qualified clinician before starting any peptide protocol.